SurgLine International EBIT

SurgLine International posts a EBIT of $-2.4M as of July 2012. That compares with $-350K in the prior-year period — down 591.5% year over year. That is below the Technology sector average of $8.3T. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, SurgLine International's EBIT was $-350K. The latest reading is $-2.4M — a 591.5% year-over-year decrease (period ending July 2012). Use the history and growth charts on this page for a longer lookback.

For Technology stocks, a EBIT near $8.3T is typical. SurgLine International's $-2.4M is lower that level. That is roughly 100.0% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

EBIT is one piece of SurgLine International's financial statement story. At $-2.4M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for SGLN's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $8.3T), and (3) consistency with growth and profitability. This page covers the first two; SurgLine International's other metric pages and overview cover the third.